Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
about
Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study.Overall survival advantage with partial nephrectomy: a bias of observational data?Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival.Combining information from cancer registry and medical records data to improve analyses of adjuvant cancer therapies.Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study.A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea: a population-based investigation.Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States.Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study.Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm.Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.Comparison of comorbidity collection methodsVariation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancerEffect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan.A combined comorbidity score predicted mortality in elderly patients better than existing scores.Evaluation of initial participation in public reporting of American College of Surgeons NSQIP surgical outcomes on Medicare's Hospital Compare website.Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.The influence of comorbidities on overall survival among older women diagnosed with breast cancer.Survival of patients with stage IV lung cancer with diabetes treated with metformin.Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis.Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study.Influence of Using Different Databases and 'Look Back' Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers.Contribution of individual diseases to death in older adults with multiple diseases.Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based modelOvarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008.Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?Re-examining the significance of surgical volume to breast cancer survival and recurrence versus process quality of care in Taiwan.Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States.A Biobehavioral [corrected] Framework to Address the Emerging Challenge of Multimorbidity.Risk of advanced-stage breast cancer among older women with comorbiditiesDiffusion of surgical innovation among patients with kidney cancer.Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer.Prognosis in HIV-infected patients with non-small cell lung cancer.The contribution of longitudinal comorbidity measurements to survival analysis.Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score AnalysisImpact of alternative approaches to assess outlying and influential observations on health care costs.Multimorbidity and access to major cancer surgery at high-volume hospitals in a regionalized era.
P2860
Q30576997-12259B89-A201-4C26-A793-3AF87311C3F2Q30626270-6FEA3E36-9A77-438D-8B4F-C48B5E0916E9Q30719268-1C8BB4CC-C40D-4300-967D-A0374DDD1EE6Q33408350-5D112FF4-20AD-4E2F-AF89-5AE167B173AEQ33559153-E62C6912-D560-43FF-A70B-A2E06827425BQ33655643-8763C0C3-8FC8-4994-BCBE-2ADEFDD8410CQ33718192-E48A9302-8060-42B9-B54F-FB601E84B616Q33890507-AF43CE59-78DD-4503-B149-722BB6E83B48Q33897653-489418D3-21A2-4FC5-8F36-D230BF9BAC86Q33925666-C072E7DE-D875-4AD3-BC45-C8B615C68DBDQ33984505-9BC9D2EF-7FFD-44B6-AC9E-39CE07D22030Q33998094-32094C08-027B-46E9-8041-78F5657D42ACQ34550547-FB32E42F-660A-4B73-97FC-B0AE9AC44EB7Q34974191-F2DB7A7B-472F-433F-8BC1-5557E328F4DAQ35000472-D2021CFB-6D22-4959-85A6-1A99FECE14C0Q35073925-0CAAFEEF-A995-472E-8D17-A414E77EE66DQ35104573-63E81A33-6756-4A81-8B9F-2145632E183FQ35107345-5336EAE3-64E7-4453-8811-71DC30FFD8A9Q35115245-7101D3A3-2ECB-479A-9A48-20279CF63961Q35153493-7EDDB2E5-7537-47E3-8A14-AD2644602EF0Q35937845-432576EA-2CD3-404D-8F61-FC0D194C0230Q36114623-493DAA2B-7FFA-4C92-8DA1-3F8EB6D6C478Q36119697-3BB4A633-942F-4979-887A-1D7C56FC326CQ36164869-BAE703D9-5364-47D2-99AA-9EA09AD37229Q36319704-96A8DA94-3974-4F68-90ED-3EA5B1A737A5Q36399784-9328FBCA-ABA4-4DD5-B9AD-2446EFC19448Q36490061-81012690-1764-4129-A9C2-0E887BC3120AQ36659650-01A5FCFD-1CF8-4F4F-BC68-DE4AF8DDF489Q36661465-C176C86A-8AEC-415E-BE26-746093CAFAA4Q36944792-78EF87A2-AF9D-456F-9C33-7906794CC6FAQ36956374-69075FE1-A6C8-4A03-9C47-983EB00A774DQ37062924-E1EECA13-992A-492B-B903-72BDE475009DQ37116172-C1B5E388-6F8A-4564-95EE-8BE28B3A1CA2Q37163534-BC9C3061-1227-443F-9B44-64BFC5435C94Q37211508-A2D5D0BD-5BCF-4800-AF6A-442C0466F9E4Q37214373-546E3911-2235-429E-9C51-3676D9FF39F0Q37241655-850F8830-A3AA-4E2E-A1B6-3410C2E64BBAQ37294190-70E78829-0DD9-409D-8339-233A0EC4D680Q37349275-180E0BB2-14B4-46D0-BE52-7AEE2A4492B9Q37603160-285DFB85-3786-4633-AC14-6D524718368A
P2860
Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Data sources for measuring com ...... re claims for cancer patients.
@ast
Data sources for measuring com ...... re claims for cancer patients.
@en
type
label
Data sources for measuring com ...... re claims for cancer patients.
@ast
Data sources for measuring com ...... re claims for cancer patients.
@en
prefLabel
Data sources for measuring com ...... re claims for cancer patients.
@ast
Data sources for measuring com ...... re claims for cancer patients.
@en
P2093
P1433
P1476
Data sources for measuring com ...... re claims for cancer patients.
@en
P2093
Carrie N Klabunde
Joan L Warren
Linda C Harlan
P304
P356
10.1097/01.MLR.0000223480.52713.B9
P577
2006-10-01T00:00:00Z